PHOENIX, Ariz., Oct. 18 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. , developer and distributor of the expanded line of Zicam(R) products, announced today that third quarter financial results will be released after the market closes on Monday, October 25, 2004. An earnings conference call will be held the following morning on Tuesday, October 26, 2004 at 11:00 a.m. ET.
To access the teleconference, please call (877) 356-5706 (domestic) or (706) 643-0580 (international). To listen to the teleconference via the Internet, go to http://www.matrixxinc.com/ and click on the third quarter 2004 teleconference icon.
A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 1504002 for 3 days following the call, and the web cast will be archived on the company's website, http://www.matrixxinc.com/, for 30 days.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter (OTC) pharmaceuticals, which utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) Cold Remedy nasal gel, a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables; Zicam Cold Remedy Oral Mist; and Zicam Cold Remedy RapidMelts; Zicam Allergy Relief; Zicam Cold Remedy Swabs; Zicam Kids Size Cold Remedy Swabs; Zicam Extreme Congestion Relief; Zicam Sinus Relief; and Zicam Nasal Moisturizer. Additionally, in July 2004 Matrixx began distributing six new Cough Mist products for the 2004-2005 cough/cold season. For more information regarding Matrixx products, go to http://www.zicam.com/. To find out more about Matrixx Initiatives, Inc , visit our website at http://www.matrixxinc.com/. For additional information, contact William Hemelt, chief financial officer, 602-385-8888, whemelt@matrixxinc.com, or Bill Barba, investor relations, at 602-385-8888, bbarba@matrixxinc.com. Matrixx is located at 4742 N. 24th Street, Suite 455, Phoenix, Arizona 85016.
Matrixx Initiatives, Inc.
To access the teleconference, please call (877) 356-5706 (domestic) or (706) 643-0580 (international). To listen to the teleconference via the Internet, go to http://www.matrixxinc.com/ and click on the third quarter 2004 teleconference icon.
A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 1504002 for 3 days following the call, and the web cast will be archived on the company's website, http://www.matrixxinc.com/, for 30 days.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter (OTC) pharmaceuticals, which utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) Cold Remedy nasal gel, a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables; Zicam Cold Remedy Oral Mist; and Zicam Cold Remedy RapidMelts; Zicam Allergy Relief; Zicam Cold Remedy Swabs; Zicam Kids Size Cold Remedy Swabs; Zicam Extreme Congestion Relief; Zicam Sinus Relief; and Zicam Nasal Moisturizer. Additionally, in July 2004 Matrixx began distributing six new Cough Mist products for the 2004-2005 cough/cold season. For more information regarding Matrixx products, go to http://www.zicam.com/. To find out more about Matrixx Initiatives, Inc , visit our website at http://www.matrixxinc.com/. For additional information, contact William Hemelt, chief financial officer, 602-385-8888, whemelt@matrixxinc.com, or Bill Barba, investor relations, at 602-385-8888, bbarba@matrixxinc.com. Matrixx is located at 4742 N. 24th Street, Suite 455, Phoenix, Arizona 85016.
Matrixx Initiatives, Inc.
